Article History
Received: 11 June 2022
Revised: 27 July 2022
Accepted: 27 July 2022
First Online: 9 August 2022
Competing interests
: AJ is co-founder, director, and SAB chair of PTC Therapeutics Inc. All other authors declare no competing interests.